Use of Stem Cells for Ischemic Cardiomyopathy

• Autores: Guo-You Zhang, Qing-Feng Li
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 14, 2013, págs. 1458-1459
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Dr Hare and colleagues1 investigated the efficacy and safety of allogeneic mesenchymal stem cells (MSCs) administered by transendocardial stem cell injection compared with autologous MSCs in patients with chronic left ventricular dysfunction secondary to myocardial infarction. The results are encouraging; however, we have some concerns about the study.